Sure, here is a list of successful research papers illustrating each of the 3 research fields outlined in my previous reply. The following papers were extracted from Semantic Scholar and chosen for their volume of Highly Influential Citations (figures reported as of May 5th 2023):

- **CRISPR/Cas Systems**: "*CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia*" by Frangoul et al., published in The New England Journal of Medicine (Dec. 2020). It reports a clinical trial of CRISPR on two patients with aggravated genetic blood disorders, one with β-Thalassemia and the other with sickle cell disease. Both had their own blood stem cells edited using the same CRISPR-Cas9 method. A year later, both patients showed successful editing in their bone marrow and blood, increased levels of fetal hemoglobin and reported no longer needing blood transfusions. As of May 5th 2023, the paper has over 449 citations according to Semantic Scholar (https://www.semanticscholar.org/paper/CRISPR-Cas9-Gene-Editing-for-Sickle-Cell-Disease-Frangoul-Altshuler/07c69f7ddd34ca8c80618e16981e2fbdb0de6529).

- **Somatic gene therapies**: "*Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy*" by Moretti and al., published in Nature Medecine (Apr 2021). This paper reports clinal trials on pig and human muscles of somatic gene editing (SDE) and validates SDE for helping patients with dysfunctional dystrophin protein generation (which causes heart and muscle failure).  As of May 5th 2023, the paper has over 9 citations (including 6 Highly Influential Citations) according to Semantic Scholar (https://www.semanticscholar.org/paper/Somatic-gene-editing-ameliorates-skeletal-and-in-of-Moretti-Fonteyne/24b6328030de292dafeae6ffd1f1d3506bb3e2e6).

- **Germline and heritable human genome editing**: "*Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells*" by Vanessa and al., published in the Oxford Academic Human Reproduction Update (June 2016). This research article outlines promising applications of CRISPR/Cas9 systems for editing genes in human reproductive cells (like eggs, sperm, and embryos), while also discussing potential societal and ethical implications. As of May 5th 2023, the paper has over 85 citations according to Semantic Scholar (https://www.semanticscholar.org/paper/Genome-engineering-through-CRISPR-Cas9-technology-Vassena-Heindryckx/317d2efeda8941522fff0482980fc1df709db0c5).

Note that while I listed CRISPR/Cas, somatic and germline genome editing separately in my previous reply, it would be more accurate to qualify CRISPR/Cas as a novel RNA gene editing that can be applied to a wide range of therapies such as: somatic gene therapies, germline gene therapies, genetic blood therapies, etc.
spam fails_task lang_mismatch pii not_appropriate hate_speech sexual_content quality toxicity humor helpfulness creativity violence